drugset / Trial / NCT04653415

Large Doses of Methylprednisolone Combined With Gabapentin in Total Knee Arthroplasty

NCT04653415

Phase 4 Completed 160 enrolled Jagiellonian University
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of the study was to assess whether administration of gabapentin and methylprednisolone as "pre-emptive analgesia" in a group of patients above 65 years of age would be effective in complex pain management therapy following total knee arthroplasty (TKA). For the study investigators will qualify one hundred seventy, above 65 years old patients. The participants will be double-blind randomized into two groups: the study and controls The study group will receive as "pre-emptive" analgesia a single dose of 300 mg oral gabapentin and 125 mg intravenous methylprednisolone, while the others placebo. Perioperatively, all the patients will receive opioid and nonopioid analgesic agents calculated for 1 kg of body weight. Investigators will measure the levels of inflammatory markers (leukocytosis, C-reactive protein - CRP), pain intensity level at rest (numerical rating scale - NRS), the life parameters and all complications.

Timeline

Start
2019-06-01
Primary completion
2020-01-01
Completion
2020-05-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gabapentin Small molecule 300 mg Oral
Comparator Methylprednisolone Other / unclassified 125 mg Intravenous

Indications